BioSpace News Archive

Pharm Country

UroGen Pharma Announces March 2020 Investor Conference Schedule

UroGen Pharma Ltd. (Nasdaq:URGN) a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options, today announced that it will participate in fireside chats at the following conferences in March

February 25, 2020

·

1 min read

BioMidwest

Allscripts TouchWorks® EHR 20.0 now generally available

New version supports interoperability standards and runs on Chrome

February 25, 2020

·

2 min read

Genetown

Dr. Thomas Cannell, President and CEO of Sesen Bio, to Host Conference Call to Provide Business Update Highlighting Regulatory Progress and Commercial Opportunity for Vicinium®

Sesen Bio announced that Dr. Thomas Cannell, President and CEO, will host a conference call on Monday, March 16, 2020 at 8:00 a.m. ET to provide an overview of 2019 operational performance and key updates on the Company’s regulatory progress and commercial opportunity for Vicinium.

February 25, 2020

·

4 min read

Business

Sangamo Therapeutics Announces Fourth Quarter and Full Year 2019 Conference Call and Webcast

Sangamo Therapeutics, Inc., a genomic medicine company, announced that the Company has scheduled the release of its fourth quarter and full year 2019 financial results before market opens on Friday, February 28, 2020.

February 25, 2020

·

1 min read

Business

Supernus Announces Fourth Quarter and Full Year 2019 Financial Results

Supernus Pharmaceuticals, Inc., a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, reported financial results for the fourth quarter and full year of 2019, and associated Company developments.

February 25, 2020

·

13 min read

Pharm Country

Medication Treatments Led to 80 Percent Lower Risk of Fatal Overdose for Patients with Opioid Use Disorder than Medication-free Treatments

Patients with opioid use disorder receiving treatment with opioid agonists had an 80 percent lower risk of dying from an opioid overdose compared to patients in treatment without the use of medications.

February 25, 2020

·

4 min read

Vertex Announces Availability of Cystic Fibrosis Medicine KALYDECO® (ivacaftor) in New Zealand

Vertex Pharmaceuticals Incorporated announced that KALYDECO® will be available to eligible patients with cystic fibrosis in New Zealand from March 1.

February 25, 2020

·

4 min read

Business

Biohaven Pharmaceuticals Reports Fourth Quarter And Full Year 2019 Financial Results And Recent Business Developments

Prescription Drug User Fee Act (PDUFA) date for rimegepant Zydis® orally dissolving tablet (ODT) set for 1Q2020 and Company prepared for commercialization

February 25, 2020

·

23 min read

Deals

Thermo Fisher Scientific Increases Quarterly Dividend payable on April 16, 2020

Thermo Fisher Scientific Inc., the world leader in serving science, announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per common share, payable on April 16, 2020, to shareholders of record as of March 16, 2020.

February 25, 2020

·

1 min read

Drug Development

Menlo Therapeutics to Host Conference Call Tomorrow to Discuss Results from Phase 2 Trial of Serlopitant in Patients with Chronic Pruritus of Unknown Origin

Menlo Therapeutics Inc., a late-stage biopharmaceutical company, announced it will host a conference call and webcast on Wednesday, February 26, 2020 at 8:30 am ET to discuss results from the Phase 2 trial of serlopitant in patients with chronic pruritus of unknown origin.

February 25, 2020

·

1 min read